[ NewLeaf Symbiotics raises $24M in Series C ]

NewLeaf Symbiotics has raised $24 million in Series C funding.

Founded in 2012, NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs.

NewLeaf will use the invested capital to commercialize seed treatment and in-furrow products for soybeans, corn, wheat, peanuts, and other crops. The company is tripling the size of its R&D and pilot production facility in St. Louis and is expanding its proprietary Prescriptive Biologics Knowledgebase™ bioinformatics platform.

Funding  Series C
Founded  2012
Country  USA
City  St Louis, Missouri
Founder / CEO  Thomas Laurita
Deal Size  $24M
Investors  Monsanto Growth Ventures (MGV)
 RockPort Capital
 Otter Capital
 Lewis & Clark Ventures
 Pangaea Ventures
 Open Prairie
Previous Investors  Palo Alto Investors
 Pangaea Ventures
 RockPort Capital
 Open Prairie